Lung Cancer
Conditions
Keywords
chest tube, lung resection, air leakage
Brief summary
This study is designed to compare the electronic chest drainage system (Drentech Palm Evo) with the traditional system, both already in use in the clinical practice, in a cohort of patients who received thoracoscopic lobectomy. This study is not evaluating safety or efficacy of these systems. This study's primary aim is to determine if the use of a digital chest system compared with a traditional system reduce the duration of chest drainage and length of hospital stay. Moreover, the investigators aim to quantify the variability of results regarding the subjective observer evaluation of active air leaks (through the traditional system) compared with the objective data registered by the digital system. Finally the investigators want to evaluate whether it is possible through the digital device to distinguish an active air leak from a pleural space effect by the evaluation of intrapleural differential pressure and to identify potential predictors of prolonged air leaks.
Interventions
Patients in the intervention arm are connected to Drentech Palm Evo with single standard chest tube (28 Ch) immediately after closure of the chest. Patients with digital devices are managed by setting the pump to -20 cmH2O until the morning of postoperative day (POD) 1 and then setting the pump on physiologic mode (0 cmH2O) thereafter. Management of chest tube drainage and decision for chest tube removal will be dictated by clinical signs, symptoms and surgeon preference following standard clinical practice of general thoracic patients
Sponsors
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
Vito Fazzi Hospital
Monaldi Hospital
University Hospital Padova
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
NONE
Intervention model description
Allocation: randomization 1 to 1 Endpoint classification: efficacy study Masking: Open label Intervention model: parallel assignment Primary purpose: supportive care
Eligibility
Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No
Inclusion criteria
* Able and willing to read, understand and provide written informed consent * Patients undergoing thoracoscopic lobectomy * Age 18 - 80 years * Gender: both * Estimated life expectancy of at least 6 months. * Tumour considered potentially resectable by R0 surgery * Adequate respiratory function for surgery. * Must have signed and dated an informed consent form (ICF), before performance of any study-specific procedures or tests. Subjects must be fully informed about their illness and the investigational nature of the study protocol.
Exclusion criteria
* Patients requiring ICU care with mechanical ventilation * Patients needing reintervention during postoperative care * Patients requiring a thoracotomy * Tumour considered potentially resectable by incomplete surgical resection with microscopic residual disease (R1) or gross residual disease (R2). * Evidence of extra-thoracic disease. * Major thoracic surgical procedure before enrolment. * Any other significant co-morbid condition that, in opinion of the investigator, would impair study participation or cooperation.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Duration of chest drainage | from date of surgery to date of chest tube removal, assessed up to 8 days |
| Post-operative hospital length of stay | from date of surgery to date of hospital discharge, assessed up to 8 days |
| Evaluation of the degree of concordance between the subjective observer evaluation of active air leaks compared with the objective data registered by the digital system in the patients with electronic chest drainage system | from date of surgery to date of chest tube removal, assessed up to 8 days |
Secondary
| Measure | Time frame |
|---|---|
| Evaluation of intrapleural differential pressure in case of active air leak and in case of pleural space effect | from date of surgery to date of chest tube removal, assessed up to 8 days |
| Identification of potential predictors of prolonged air leaks through the analysis of the data registered by the digital system | from date of surgery to date of chest tube removal, assessed up to 8 days |
Countries
Italy
Contacts
Primary ContactGiuseppe Marulli, MD, PhD
Backup ContactGiovanni Comacchio, MD
Outcome results
None listed